NEW YORK (GenomeWeb News) – The Indian therapeutics and drug development services firm Advinus Therapeutics will collaborate with Corning to offer Corning's Epic label-free detection services in India.
Under the agreement, Pune-based Advinus will use the Epic technology in its drug discovery capabilities and to provide assay development and screening services in India and abroad. Financial and other terms were not disclosed.
The Corning detection technology is used to identify targets, pathways, and interactions, providing data for use in drug development.
"This collaboration highlights the growing adoption of label-free technology and the biological insights it enables in drug discovery research," Ron Verkleeren, director of advanced life sciences for Corning, said in a statement. "We believe this is an important step forward in making our Epic technology more accessible to life science researchers worldwide."
Advinus offers end-to-end development services, is developing its own drug candidates, and in its center in Bangalore provides pre-clinical and early clinical drug development services.